McCann Health Engagement
As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
CMI Media Group
CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Lynx
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
Company Details
Latest Content from PMHub
An animated approach to communicating healthy messages | Pegasus
Videos and Podcasts | March 18, 2016 | Inizio
Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...
Focus on multiple myeloma treatment: Witnessing a transformation
White Papers and Resources | March 15, 2016 | Blue Latitude Health
Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.
The ROI of user experience in pharma and healthcare: How to engage your customers
White Papers and Resources | March 14, 2016 | Blue Latitude Health
In this article, Head of Customer Experience Elisa del Galdo of Blue Latitude Health breaks down how to understand the return on investment of user experience in pharma and healthcare.
Why health psychology should inform pharma strategy
Press Releases | March 10, 2016 | Lucid Group Communications Limited
In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform...
Pegasus shortlisted for four PM Society Digital Media Awards 2016
Press Releases | March 8, 2016 | Inizio
Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016...
Why does content need a strategy?
White Papers and Resources | March 7, 2016 | Blue Latitude Health
Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy? Content Marketing...
Seven ways to make centrally-produced content fit affiliates’ needs
White Papers and Resources | March 3, 2016 | Anthill Agency
It’s common to encounter some degree of local resistance to centrally-produced sales materials. But don’t despair. A few simple content strategies can make a huge difference. Here are seven ideas...
Lucid Group celebrate 9 years of changing patients’ lives
Press Releases | March 3, 2016 | Lucid Group Communications Limited
Lucid Group had fun and games celebrating their nine year anniversary in their London offices last week. Lucid has grown from the two founders working out of a basement to...
Infographic: HCV EU
White Papers and Resources | March 3, 2016 | Inizio
Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction...
Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market
White Papers and Resources | March 3, 2016 | Inizio
Published in eyeforpharma February 2016 by Rachel Howard